Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Malaysia Team Up to Promote Biotech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today signed a memorandum of understanding with the Malaysian government to promote and develop biotechnology in that country.

The MOU was reached through the Malaysian Institute of Pharmaceuticals and Nutraceuticals, or IPHARM, an agency under the Ministry of Science, Technology, and Innovation.

The alliance will focus on establishing the IPHARM-Agilent Global Reference Research Lab and developing human capital in biotechnology, Agilent said in a statement. The lab will develop global Halal testing standards in pharmaceuticals and nutraceuticals and provide access to analytical tools and expertise "to develop the local industry and small and medium enterprise ecosystem in their commercialization efforts," the company added.

Halal is a term designating that goods or actions comply with Islamic laws.

Agilent will provide its specialized technical expertise to create the lab and "leading-edge analytical and application solutions to jointly develop the global Halal testing standards with IPHARM," it said. It also will transfer its biotechnology knowledge to Malaysia "to build and develop indigenous capabilities through an ecosystem of local knowledge partners."

IPHARM contributes domain expertise in bioactive compounds research and analysis, and will leverage Malaysia's "inherited strength in biodiversity and its aspiration to be a global Halal testing leader in pharmaceuticals and nutraceuticals," Agilent said.

Gooi Soon Chai, president of Agilent Technologies Malaysia and Singapore, added that the partnership offers "enormous potential" in hastening biotechnology as Malaysia's next engine of economic growth.

Filed under

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.